Laura Prendergast

Stock Analyst at Raymond James

(1.43)

# 2,396

Out of 4,416 analysts

3

Total ratings

66.67%

Success rate

6.32%

Average return

Main Sectors:

Top Industries:

2 Stocks

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	RVMD Revolution Medicines	Upgrades: Strong Buy	$36 → $48	$40.20	+19.40%	2	Apr 10, 2024
	NKTX Nkarta	Downgrades: Outperform	$13 → $16	$7.53	+112.48%	1	Mar 22, 2024

Revolution Medicines

Apr 10, 2024

Upgrades: Strong Buy

Price Target: $36 → $48

Current: $40.20

Upside: +19.40%

Nkarta

Mar 22, 2024

Downgrades: Outperform

Price Target: $13 → $16

Current: $7.53

Upside: +112.48%